Free Trial

Nyxoah (NYXH) Competitors

Nyxoah logo
$8.18 +0.21 (+2.57%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NYXH vs. LQDA, SSII, PLSE, INMD, MDXG, KMTS, SIBN, IRMD, CBLL, and EMBC

Should you be buying Nyxoah stock or one of its competitors? The main competitors of Nyxoah include Liquidia Technologies (LQDA), SS Innovations International (SSII), Pulse Biosciences (PLSE), InMode (INMD), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), and Embecta (EMBC). These companies are all part of the "medical equipment" industry.

Nyxoah vs. Its Competitors

Liquidia Technologies (NASDAQ:LQDA) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and media sentiment.

Liquidia Technologies has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.

Liquidia Technologies has a net margin of -903.80% compared to Nyxoah's net margin of -1,571.39%. Nyxoah's return on equity of -63.37% beat Liquidia Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Liquidia Technologies-903.80% -177.91% -60.15%
Nyxoah -1,571.39%-63.37%-46.67%

Nyxoah has lower revenue, but higher earnings than Liquidia Technologies. Liquidia Technologies is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liquidia Technologies$14M89.15-$130.39M-$1.58-9.24
Nyxoah$4.36M64.62-$64.10M-$2.13-3.89

Liquidia Technologies currently has a consensus target price of $26.89, indicating a potential upside of 84.17%. Nyxoah has a consensus target price of $14.50, indicating a potential upside of 75.12%. Given Liquidia Technologies' higher probable upside, equities analysts plainly believe Liquidia Technologies is more favorable than Nyxoah.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Liquidia Technologies
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Liquidia Technologies had 20 more articles in the media than Nyxoah. MarketBeat recorded 20 mentions for Liquidia Technologies and 0 mentions for Nyxoah. Nyxoah's average media sentiment score of 1.89 beat Liquidia Technologies' score of 0.25 indicating that Nyxoah is being referred to more favorably in the news media.

Company Overall Sentiment
Liquidia Technologies Neutral
Nyxoah Very Positive

64.5% of Liquidia Technologies shares are owned by institutional investors. 26.5% of Liquidia Technologies shares are owned by insiders. Comparatively, 17.1% of Nyxoah shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Liquidia Technologies beats Nyxoah on 10 of the 16 factors compared between the two stocks.

Get Nyxoah News Delivered to You Automatically

Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NYXH vs. The Competition

MetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$282.02M$1.97B$5.50B$9.39B
Dividend YieldN/AN/A4.25%4.09%
P/E Ratio-3.8934.3528.1019.86
Price / Sales64.6211.47402.2879.25
Price / CashN/A53.6035.5357.53
Price / Book2.308.678.265.72
Net Income-$64.10M-$62.39M$3.24B$257.80M
7 Day Performance6.98%-0.78%0.50%1.06%
1 Month Performance6.98%13.29%7.99%11.30%
1 Year Performance-10.00%6.02%28.68%17.00%

Nyxoah Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
2.5397 of 5 stars
$8.28
+3.9%
$14.50
+75.1%
-15.2%$282.02M$4.36M-3.89110Positive News
LQDA
Liquidia Technologies
3.2305 of 5 stars
$12.45
+2.1%
$26.89
+116.0%
+10.6%$1.04B$14M-7.8850Insider Trade
SSII
SS Innovations International
N/A$5.27
-1.3%
N/AN/A$1.03B$20.65M0.004
PLSE
Pulse Biosciences
3.7595 of 5 stars
$15.81
+3.3%
$22.00
+39.2%
-18.5%$1.03B$700K0.00140
INMD
InMode
4.0997 of 5 stars
$15.10
-0.4%
$18.54
+22.8%
-25.2%$958.25M$394.82M6.48480News Coverage
Positive News
MDXG
MiMedx Group
3.7173 of 5 stars
$6.48
+2.2%
$12.50
+92.9%
-10.3%$936.43M$348.88M24.00870News Coverage
Analyst Forecast
KMTS
Kestra Medical Technologies
N/A$14.75
-5.9%
$27.50
+86.4%
N/A$804.64M$52.64M0.00300News Coverage
Analyst Forecast
SIBN
SiBone
3.89 of 5 stars
$18.01
-2.5%
$22.50
+24.9%
+0.8%$787.09M$167.18M-28.14350Positive News
IRMD
iRadimed
4.9236 of 5 stars
$59.02
-4.5%
$72.00
+22.0%
+23.7%$785.79M$73.24M38.08110Positive News
CBLL
CeriBell
2.662 of 5 stars
$17.20
-9.1%
$32.14
+86.9%
N/A$684.19M$65.44M0.00N/A
EMBC
Embecta
4.6848 of 5 stars
$10.03
-2.8%
$19.33
+92.8%
-26.1%$603.13M$1.08B11.142,100Analyst Forecast

Related Companies and Tools


This page (NASDAQ:NYXH) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners